Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- manufacturers
- FTO-IN-1
-
- $78.00 / 1mg
-
2024-11-19
- CAS:2243944-92-3
- Min. Order:
- Purity: 99.43%
- Supply Ability: 10g
|
| Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- Basic information |
Product Name: | Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- | Synonyms: | Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy-;UUN44923;FTO-IN-1;Dac51,UUN-44923;mass,cancer,FTO,associated,enzyme,inhibit,FTOIN1,fat,obesity,Inhibitor,FTO IN 1;2-[[2,6-Dichloro-4-(3,5-dimethyl-4-pyrazolyl)phenyl]amino]-N-hydroxybenzamide;2-((2,6-Dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl)amino)-N-hydroxybenzamide | CAS: | 2243944-92-3 | MF: | C18H16Cl2N4O2 | MW: | 391.25 | EINECS: | | Product Categories: | | Mol File: | 2243944-92-3.mol | |
| Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- Chemical Properties |
density | 1.448±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO: 100 mg/mL (197.91 mM);Water: Insoluble;Ethanol: Insoluble | pka | 8.72±0.40(Predicted) |
| Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- Usage And Synthesis |
Description | UUN44923 is a FTO inhibitor. UUN44923 may be useful for treating diseases assocd. with FTO targets, obesity, metabolic syndrome (MS)?, type 2 diabetes (T2D)?, Alzheimer's diseases, breast cancers, small-?cell lung cancers, a human bone marrow striated muscle cancer, a pancreatic cancer, malignant glioblastoma and the like. UUN44923 was reported in WO 2018157843. This product has no formal name at the moment. |
| Benzamide, 2-[[2,6-dichloro-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]-N-hydroxy- Preparation Products And Raw materials |
|